ID   TANC2_HUMAN             Reviewed;        1990 AA.
AC   Q9HCD6; Q9HAC3; Q9NW88; Q9NXY9; Q9ULS2;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 3.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=Protein TANC2;
DE   AltName: Full=Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2;
GN   Name=TANC2; Synonyms=KIAA1148, KIAA1636;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 127-1990 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 676-1990 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 843-1990 (ISOFORM 4).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 869-1990 (ISOFORM 2).
RA   Dahllund L., Sjodin J., Wikstrom L.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1448-1990 (ISOFORMS 1/2).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1442, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-238; SER-294;
RP   SER-400; SER-1458; SER-1530; SER-1545; SER-1579; SER-1722 AND SER-1827, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   VARIANT IDDALDS CYS-760.
RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,
RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,
RA   Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [14]
RP   VARIANT VAL-1280.
RX   PubMed=28493397; DOI=10.1002/humu.23246;
RG   UK10K;
RA   Rainger J., Williamson K.A., Soares D.C., Truch J., Kurian D.,
RA   Gillessen-Kaesbach G., Seawright A., Prendergast J., Halachev M.,
RA   Wheeler A., McTeir L., Gill A.C., van Heyningen V., Davey M.G.,
RA   FitzPatrick D.R.;
RT   "A recurrent de novo mutation in ACTG1 causes isolated ocular coloboma.";
RL   Hum. Mutat. 38:942-946(2017).
RN   [15]
RP   CHARACTERIZATION OF VARIANTS IDDALDS CYS-760 AND 1066-ARG--VAL-1990 DEL,
RP   INTERACTION WITH KIF1A, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=30021165; DOI=10.1016/j.celrep.2018.06.071;
RA   Stucchi R., Plucinska G., Hummel J.J.A., Zahavi E.E., Guerra San Juan I.,
RA   Klykov O., Scheltema R.A., Altelaar A.F.M., Hoogenraad C.C.;
RT   "Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca2+/CaM Controls
RT   DCV Binding and Liprin-alpha/TANC2 Recruits DCVs to Postsynaptic Sites.";
RL   Cell Rep. 24:685-700(2018).
RN   [16]
RP   INVOLVEMENT IN IDDALDS, AND VARIANTS IDDALDS HIS-755; CYS-760; VAL-794;
RP   GLN-961; 1066-ARG--VAL-1990 DEL; 1400-GLN--VAL-1990 DEL; 1483-GLN--VAL-1990
RP   DEL AND ARG-1689.
RX   PubMed=31616000; DOI=10.1038/s41467-019-12435-8;
RG   University of Washington Center for Mendelian Genomics;
RA   Guo H., Bettella E., Marcogliese P.C., Zhao R., Andrews J.C.,
RA   Nowakowski T.J., Gillentine M.A., Hoekzema K., Wang T., Wu H., Jangam S.,
RA   Liu C., Ni H., Willemsen M.H., van Bon B.W., Rinne T., Stevens S.J.C.,
RA   Kleefstra T., Brunner H.G., Yntema H.G., Long M., Zhao W., Hu Z.,
RA   Colson C., Richard N., Schwartz C.E., Romano C., Castiglia L., Bottitta M.,
RA   Dhar S.U., Erwin D.J., Emrick L., Keren B., Afenjar A., Zhu B., Bai B.,
RA   Stankiewicz P., Herman K., Mercimek-Andrews S., Juusola J., Wilfert A.B.,
RA   Abou Jamra R., Buettner B., Mefford H.C., Muir A.M., Scheffer I.E.,
RA   Regan B.M., Malone S., Gecz J., Cobben J., Weiss M.M., Waisfisz Q.,
RA   Bijlsma E.K., Hoffer M.J.V., Ruivenkamp C.A.L., Sartori S., Xia F.,
RA   Rosenfeld J.A., Bernier R.A., Wangler M.F., Yamamoto S., Xia K.,
RA   Stegmann A.P.A., Bellen H.J., Murgia A., Eichler E.E.;
RT   "Disruptive mutations in TANC2 define a neurodevelopmental syndrome
RT   associated with psychiatric disorders.";
RL   Nat. Commun. 10:4679-4679(2019).
CC   -!- FUNCTION: Scaffolding protein in the dendritic spines which acts as
CC       immobile postsynaptic posts able to recruit KIF1A-driven dense core
CC       vesicles to dendritic spines. {ECO:0000269|PubMed:30021165}.
CC   -!- SUBUNIT: Interacts with KIF1A; the interaction decreases in presence of
CC       calcium. {ECO:0000269|PubMed:30021165}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:30021165}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9HCD6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCD6-2; Sequence=VSP_033550;
CC       Name=3;
CC         IsoId=Q9HCD6-3; Sequence=VSP_033546, VSP_033547;
CC       Name=4;
CC         IsoId=Q9HCD6-4; Sequence=VSP_033548, VSP_033549;
CC   -!- DISEASE: Intellectual developmental disorder with autistic features and
CC       language delay, with or without seizures (IDDALDS) [MIM:618906]: An
CC       autosomal dominant neurodevelopmental disorder characterized by global
CC       developmental delay, varying degrees of intellectual disability, autism
CC       spectrum disorder, and delayed language. Some patients develop
CC       seizures. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:30021165,
CC       ECO:0000269|PubMed:31616000}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in TANC2 has been found in a patient with
CC       isolated coloboma, a defect of the eye characterized by the absence of
CC       ocular structures due to abnormal morphogenesis of the optic cup and
CC       stalk, and the fusion of the fetal fissure (optic fissure). Isolated
CC       colobomas may be associated with an abnormally small eye
CC       (microphthalmia) or small cornea. {ECO:0000269|PubMed:28493397}.
CC   -!- SIMILARITY: Belongs to the TANC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB92314.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB92314.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAB92314.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005828; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005972; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006270; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC015923; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046856; BAB13462.2; -; mRNA.
DR   EMBL; AK001077; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK021886; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ278120; CAB92314.1; ALT_SEQ; mRNA.
DR   EMBL; AB032974; BAA86462.2; -; mRNA.
DR   CCDS; CCDS45754.1; -. [Q9HCD6-1]
DR   CCDS; CCDS92375.1; -. [Q9HCD6-2]
DR   RefSeq; NP_079461.2; NM_025185.3. [Q9HCD6-1]
DR   RefSeq; XP_005257260.1; XM_005257203.4.
DR   AlphaFoldDB; Q9HCD6; -.
DR   SMR; Q9HCD6; -.
DR   BioGRID; 117559; 79.
DR   IntAct; Q9HCD6; 20.
DR   MINT; Q9HCD6; -.
DR   STRING; 9606.ENSP00000387593; -.
DR   GlyCosmos; Q9HCD6; 6 sites, 1 glycan.
DR   GlyGen; Q9HCD6; 9 sites, 1 O-linked glycan (8 sites).
DR   iPTMnet; Q9HCD6; -.
DR   PhosphoSitePlus; Q9HCD6; -.
DR   BioMuta; TANC2; -.
DR   DMDM; 189029946; -.
DR   EPD; Q9HCD6; -.
DR   jPOST; Q9HCD6; -.
DR   MassIVE; Q9HCD6; -.
DR   MaxQB; Q9HCD6; -.
DR   PaxDb; Q9HCD6; -.
DR   PeptideAtlas; Q9HCD6; -.
DR   ProteomicsDB; 81677; -. [Q9HCD6-1]
DR   ProteomicsDB; 81678; -. [Q9HCD6-2]
DR   ProteomicsDB; 81679; -. [Q9HCD6-3]
DR   ProteomicsDB; 81680; -. [Q9HCD6-4]
DR   Antibodypedia; 9399; 14 antibodies from 9 providers.
DR   DNASU; 26115; -.
DR   Ensembl; ENST00000389520.8; ENSP00000374171.4; ENSG00000170921.16. [Q9HCD6-2]
DR   Ensembl; ENST00000424789.6; ENSP00000387593.2; ENSG00000170921.16. [Q9HCD6-1]
DR   GeneID; 26115; -.
DR   KEGG; hsa:26115; -.
DR   UCSC; uc002jal.5; human. [Q9HCD6-1]
DR   AGR; HGNC:30212; -.
DR   CTD; 26115; -.
DR   DisGeNET; 26115; -.
DR   GeneCards; TANC2; -.
DR   HGNC; HGNC:30212; TANC2.
DR   HPA; ENSG00000170921; Tissue enhanced (parathyroid).
DR   MalaCards; TANC2; -.
DR   MIM; 615047; gene.
DR   MIM; 618906; phenotype.
DR   neXtProt; NX_Q9HCD6; -.
DR   OpenTargets; ENSG00000170921; -.
DR   Orphanet; 528084; Non-specific syndromic intellectual disability.
DR   PharmGKB; PA142670837; -.
DR   VEuPathDB; HostDB:ENSG00000170921; -.
DR   eggNOG; KOG0504; Eukaryota.
DR   GeneTree; ENSGT00940000156447; -.
DR   HOGENOM; CLU_001464_0_1_1; -.
DR   InParanoid; Q9HCD6; -.
DR   OMA; XRKIPDE; -.
DR   OrthoDB; 4130451at2759; -.
DR   PhylomeDB; Q9HCD6; -.
DR   TreeFam; TF323159; -.
DR   PathwayCommons; Q9HCD6; -.
DR   SignaLink; Q9HCD6; -.
DR   SIGNOR; Q9HCD6; -.
DR   BioGRID-ORCS; 26115; 13 hits in 1153 CRISPR screens.
DR   ChiTaRS; TANC2; human.
DR   GenomeRNAi; 26115; -.
DR   Pharos; Q9HCD6; Tdark.
DR   PRO; PR:Q9HCD6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9HCD6; protein.
DR   Bgee; ENSG00000170921; Expressed in cortical plate and 165 other tissues.
DR   ExpressionAtlas; Q9HCD6; baseline and differential.
DR   Genevisible; Q9HCD6; HS.
DR   GO; GO:0030424; C:axon; IEA:GOC.
DR   GO; GO:0043197; C:dendritic spine; IDA:UniProtKB.
DR   GO; GO:0099519; P:dense core granule cytoskeletal transport; ISS:UniProtKB.
DR   GO; GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 2.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR24166:SF21; PROTEIN TANC2; 1.
DR   PANTHER; PTHR24166; ROLLING PEBBLES, ISOFORM B; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF13181; TPR_8; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 11.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF48452; TPR-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 6.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Autism spectrum disorder;
KW   Cell projection; Disease variant; Glycoprotein; Intellectual disability;
KW   Methylation; Phosphoprotein; Reference proteome; Repeat; Synapse;
KW   TPR repeat.
FT   CHAIN           1..1990
FT                   /note="Protein TANC2"
FT                   /id="PRO_0000333811"
FT   REPEAT          846..878
FT                   /note="ANK 1"
FT   REPEAT          884..913
FT                   /note="ANK 2"
FT   REPEAT          917..946
FT                   /note="ANK 3"
FT   REPEAT          950..979
FT                   /note="ANK 4"
FT   REPEAT          990..1019
FT                   /note="ANK 5"
FT   REPEAT          1033..1062
FT                   /note="ANK 6"
FT   REPEAT          1066..1095
FT                   /note="ANK 7"
FT   REPEAT          1099..1128
FT                   /note="ANK 8"
FT   REPEAT          1132..1161
FT                   /note="ANK 9"
FT   REPEAT          1165..1194
FT                   /note="ANK 10"
FT   REPEAT          1198..1227
FT                   /note="ANK 11"
FT   REPEAT          1244..1277
FT                   /note="TPR 1"
FT   REPEAT          1291..1324
FT                   /note="TPR 2"
FT   REPEAT          1325..1358
FT                   /note="TPR 3"
FT   REGION          1..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          129..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          396..442
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1372..1401
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1430..1586
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1692..1718
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1783..1803
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1821..1843
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1968..1990
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..38
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        417..434
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1377..1392
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1446..1512
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1524..1540
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1550..1576
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1823..1842
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15144186"
FT   MOD_RES         1458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1530
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1545
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1563
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:A2A690"
FT   MOD_RES         1576
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:A2A690"
FT   MOD_RES         1579
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1722
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1824
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2A690"
FT   MOD_RES         1827
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CARBOHYD        1928
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:A2A690"
FT   VAR_SEQ         944..971
FT                   /note="VDHLDKNGQCALVHAALRGHLEVVKFLI -> VLAAQLCCFSSLFLYFRCIL
FT                   FLISSVTS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_033546"
FT   VAR_SEQ         972..1990
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_033547"
FT   VAR_SEQ         1006..1010
FT                   /note="IVSYL -> VRSRQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_033548"
FT   VAR_SEQ         1011..1990
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_033549"
FT   VAR_SEQ         1225
FT                   /note="I -> IGCQTLPSRPR (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_033550"
FT   VARIANT         755
FT                   /note="R -> H (in IDDALDS; unknown pathological
FT                   significance; dbSNP:rs775421108)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084328"
FT   VARIANT         760
FT                   /note="R -> C (in IDDALDS; reduced interaction with KIF1A;
FT                   impaired neuronal dense core vesicles transport; no effect
FT                   on dendritic spine location; dbSNP:rs1282488329)"
FT                   /evidence="ECO:0000269|PubMed:23033978,
FT                   ECO:0000269|PubMed:30021165, ECO:0000269|PubMed:31616000"
FT                   /id="VAR_069374"
FT   VARIANT         794
FT                   /note="A -> V (in IDDALDS; unknown pathological
FT                   significance; dbSNP:rs2047545401)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084329"
FT   VARIANT         961
FT                   /note="R -> Q (in IDDALDS; unknown pathological
FT                   significance; dbSNP:rs374131489)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084330"
FT   VARIANT         1066..1990
FT                   /note="Missing (in IDDALDS; strongly reduced interaction
FT                   with KIF1A; strongly reduced localization at the dendritic
FT                   spine)"
FT                   /evidence="ECO:0000269|PubMed:30021165,
FT                   ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084331"
FT   VARIANT         1280
FT                   /note="G -> V (found in a patient with isolated coloboma;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28493397"
FT                   /id="VAR_079853"
FT   VARIANT         1400..1990
FT                   /note="Missing (in IDDALDS)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084332"
FT   VARIANT         1483..1990
FT                   /note="Missing (in IDDALDS)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084333"
FT   VARIANT         1689
FT                   /note="H -> R (in IDDALDS; unknown pathological
FT                   significance; dbSNP:rs2049010059)"
FT                   /evidence="ECO:0000269|PubMed:31616000"
FT                   /id="VAR_084334"
FT   CONFLICT        1210
FT                   /note="R -> P (in Ref. 4; CAB92314)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1234
FT                   /note="T -> P (in Ref. 4; CAB92314)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1249
FT                   /note="E -> K (in Ref. 4; CAB92314)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1285
FT                   /note="T -> P (in Ref. 4; CAB92314)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1990 AA;  219650 MW;  E835D98F5C546365 CRC64;
     MFRNSLKMLL TGGKSSRKNR SSDGGSEEPP DRRQSSVDSR QSRSGQGGIS TESDCAFEPD
     YAVPPLPVSE GDAEQELGPP PSVDEAANTL MTRLGFLLGE KVTEVQPGDQ YSMEVQDENQ
     TSAITQRISP CSTLTSSTAS PPASSPCSTL PPISTNATAK DCSYGAVTSP TSTLESRDSG
     IIATLTSYSE NVERTKYAGE SSKELGSGGN IKPWQSQKSS MDSCLYRVDE NMTASTYSLN
     KIPERNLETV LSQSVQSIPL YLMPRPNSVA ATSSAHLEDL AYLDEQRHTP LRTSLRMPRQ
     SMGGARTQQD LRVRFAPYRP PDISLKPLLF EVPSITTESV FVGRDWVFHE IDAQLQSSNA
     SVNQGVVIVG NIGFGKTAII SRLVALSCHG TRMRQIASDS PHASPKHVDA NRELPLTQPP
     SAHSSITSGS CPGTPEMRRR QEEAMRRLAS QVVAYHYCQA DNAYTCLVPE FVHNVAALLC
     RSPQLTAYRE QLLREPHLQS MLSLRSCVQD PMASFRRGVL EPLENLHKER KIPDEDFIIL
     IDGLNEAEFH KPDYGDTIVS FLSKMIGKFP SWLKLIVTVR TSLQEITKLL PFHRIFLDRL
     EENEAIDQDL QAYILHRIHS SSEIQNNISL NGKMDNTTFG KLSSHLKTLS QGSYLYLKLT
     FDLIEKGYLV LKSSSYKVVP VSLSEVYLLQ CNMKFPTQSS FDRVMPLLNV AVASLHPLTD
     EHIFQAINAG SIEGTLEWED FQQRMENLSM FLIKRRDMTR MFVHPSFREW LIWREEGEKT
     KFLCDPRSGH TLLAFWFSRQ EGKLNRQQTI ELGHHILKAH IFKGLSKKVG VSSSILQGLW
     ISYSTEGLSM ALASLRNLYT PNIKVSRLLI LGGANINYRT EVLNNAPILC VQSHLGYTEM
     VALLLEFGAN VDASSESGLT PLGYAAAAGY LSIVVLLCKK RAKVDHLDKN GQCALVHAAL
     RGHLEVVKFL IQCDWTMAGQ QQGVFKKSHA IQQALIAAAS MGYTEIVSYL LDLPEKDEEE
     VERAQINSFD SLWGETALTA AAGRGKLEVC RLLLEQGAAV AQPNRRGAVP LFSTVRQGHW
     QIVDLLLTHG ADVNMADKQG RTPLMMAASE GHLGTVDFLL AQGASIALMD KEGLTALSWA
     CLKGHLSVVR SLVDNGAATD HADKNGRTPL DLAAFYGDAE VVQFLVDHGA MIEHVDYSGM
     RPLDRAVGCR NTSVVVTLLK KGAKIGPATW AMATSKPDIM IILLSKLMEE GDMFYKKGKV
     KEAAQRYQYA LKKFPREGFG EDLKTFRELK VSLLLNLSRC RRKMNDFGMA EEFATKALEL
     KPKSYEAYYA RARAKRSSRQ FAAALEDLNE AIKLCPNNRE IQRLLLRVEE ECRQMQQPQQ
     PPPPPQPQQQ LPEEAEPEPQ HEDIYSVQDI FEEEYLEQDV ENVSIGLQTE ARPSQGLPVI
     QSPPSSPPHR DSAYISSSPL GSHQVFDFRS SSSVGSPTRQ TYQSTSPALS PTHQNSHYRP
     SPPHTSPAHQ GGSYRFSPPP VGGQGKEYPS PPPSPLRRGP QYRASPPAES MSVYRSQSGS
     PVRYQQETSV SQLPGRPKSP LSKMAQRPYQ MPQLPVAVPQ QGLRLQPAKA QIVRSNQPSP
     AVHSSTVIPT GAYGQVAHSM ASKYQSSQGD IGVSQSRLVY QGSIGGIVGD GRPVQHVQAS
     LSAGAICQHG GLTKEDLPQR PSSAYRGGVR YSQTPQIGRS QSASYYPVCH SKLDLERSSS
     QLGSPDVSHL IRRPISVNPN EIKPHPPTPR PLLHSQSVGL RFSPSSNSIS STSNLTPTFR
     PSSSIQQMEI PLKPAYERSC DELSPVSPTQ GGYPSEPTRS RTTPFMGIID KTARTQQYPH
     LHQQNRTWAV SSVDTVLSPT SPGNLPQPES FSPPSSISNI AFYNKTNNAQ NGHLLEDDYY
     SPHGMLANGS RGDLLERVSQ ASSYPDVKVA RTLPVAQAYQ DNLYRQLSRD SRQGQTSPIK
     PKRPFVESNV
//
